
Trimurthi (TRIMURTHI) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2024Income Metrics
Revenue
53.0M
Gross Profit
2.8M
5.24%
Operating Income
1.3M
2.39%
Net Income
1.5M
2.79%
EPS (Diluted)
₹0.15
Balance Sheet Metrics
Total Assets
272.1M
Cash Flow Metrics
Revenue & Profitability Trend
Trimurthi Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 307.2M | 42.2M | 14.0M | 8.4M | 92.4M |
Cost of Goods Sold | 295.7M | 38.4M | 13.5M | 8.1M | 85.7M |
Gross Profit | 11.4M | 3.9M | 523.6K | 349.9K | 6.8M |
Gross Margin % | 3.7% | 9.2% | 3.7% | 4.1% | 7.3% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 1.0M | 855.7K | 822.8K | 2.0M |
Other Operating Expenses | 9.3M | 2.2M | 1.5M | 1.5M | 2.6M |
Total Operating Expenses | 9.3M | 3.3M | 2.4M | 2.3M | 4.6M |
Operating Income | 1.1M | -1.5M | -5.7M | -5.9M | -10.4M |
Operating Margin % | 0.3% | -3.5% | -40.9% | -69.9% | -11.3% |
Non-Operating Items | |||||
Interest Income | - | 2.0M | 2.7M | 3.0M | 3.3M |
Interest Expense | - | - | - | 577.0K | 540.0K |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 1.2M | 212.6K | -584.8K | -15.7M | -37.5M |
Income Tax | 388.0K | 108.4K | 14.5K | -54.7K | 138.0K |
Effective Tax Rate % | 31.5% | 51.0% | 0.0% | 0.0% | 0.0% |
Net Income | 845.0K | 104.1K | -599.3K | -15.6M | -37.6M |
Net Margin % | 0.3% | 0.2% | -4.3% | -185.1% | -40.7% |
Key Metrics | |||||
EBITDA | 1.5M | -748.2K | -7.6M | 7.6M | -5.3M |
EPS (Basic) | - | ₹0.01 | ₹-0.07 | ₹-1.93 | ₹-4.62 |
EPS (Diluted) | - | ₹0.01 | ₹-0.07 | ₹-1.93 | ₹-4.62 |
Basic Shares Outstanding | - | 8100000 | 8100000 | 8100000 | 8100000 |
Diluted Shares Outstanding | - | 8100000 | 8100000 | 8100000 | 8100000 |
Income Statement Trend
Trimurthi Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | - | 1.2M | 2.7M | 26.0M | 20.8M |
Short-term Investments | - | 25.0M | 25.0M | 4.0M | 5.8M |
Accounts Receivable | - | 133.6K | 1.9M | 998.0K | 13.8M |
Inventory | - | 11.9M | 8.2M | 5.3M | 9.3M |
Other Current Assets | - | - | -10 | -20 | - |
Total Current Assets | - | 41.3M | 42.4M | 46.3M | 73.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | - | 0 | 1.4M | 1.4M | 123.0K |
Goodwill | - | 100 | 100 | 0 | 325.0K |
Intangible Assets | - | 100 | 100 | 106.0K | 325.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | 110 | 13.6M |
Total Non-Current Assets | 2.7M | 32.4M | 30.1M | 26.2M | 22.4M |
Total Assets | 2.7M | 73.6M | 72.6M | 72.5M | 95.7M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | - | 30.0K | 538.0K | 0 | 21.5M |
Short-term Debt | - | - | - | 337.0K | 0 |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | 71.3K | - | 131.0K | 289.0K |
Total Current Liabilities | - | 101.4K | 616.4K | 81.5K | 21.8M |
Non-Current Liabilities | |||||
Long-term Debt | 0 | - | - | 1.3M | 0 |
Deferred Tax Liabilities | - | 0 | 0 | 0 | 328.0K |
Other Non-Current Liabilities | - | - | - | - | 1.0K |
Total Non-Current Liabilities | - | 0 | 0 | 0 | 329.0K |
Total Liabilities | - | 101.4K | 616.4K | 81.5K | 22.1M |
Equity | |||||
Common Stock | - | 81.0M | 81.0M | 81.0M | 81.0M |
Retained Earnings | - | -24.1M | -24.3M | -23.7M | -27.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | - | 73.5M | 72.0M | 72.4M | 73.7M |
Key Metrics | |||||
Total Debt | 0 | 0 | 0 | 1.6M | 0 |
Working Capital | 0 | 41.2M | 41.8M | 46.2M | 51.6M |
Balance Sheet Composition
Trimurthi Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | - | 212.6K | -584.8K | -15.7M | -37.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 0 | -440.0K | -19.4M | 11.4M | 50.2M |
Operating Cash Flow | -159.0K | -2.3M | -22.7M | -7.3M | 10.3M |
Investing Activities | |||||
Capital Expenditures | - | 184.6K | -43.8K | -18.3M | -295.0K |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | -500.0K | -2.8M |
Investment Sales | - | - | 22.8M | 15.6M | 1.7M |
Investing Cash Flow | - | 184.6K | -4.4M | -3.3M | -1.4M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | 113.2M | - | - | 0 | 0 |
Free Cash Flow | - | -3.4M | -24.1M | -12.7M | 15.6M |
Net Change in Cash | 113.0M | -2.1M | -27.1M | -10.6M | 8.9M |
Cash Flow Trend
Trimurthi Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
102.35
Price to Book
2.40
Price to Sales
2.45
Profitability Ratios
Profit Margin
1.85%
Operating Margin
2.41%
Return on Assets
30.90%
Financial Health
Beta
0.62
Per Share Data
EPS (TTM)
₹0.26
Book Value per Share
₹11.10
Revenue per Share
₹11.72
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
trimurthi | 264.8M | 102.35 | 2.40 | 0.00% | 1.85% | - |
Entero Healthcare | 51.9B | 54.82 | 3.01 | 5.36% | 1.90% | 21.76 |
Amwill Health Care | 1.2B | 8.97 | 1.72 | 24.85% | 26.44% | 0.00 |
Royal Sense | 1.1B | 17.33 | 3.62 | 27.55% | 10.26% | 11.74 |
NOVELIX | 532.4M | 514.50 | 2.34 | 0.68% | 0.28% | 0.00 |
Zenlabs Ethica | 214.6M | 78.02 | 1.99 | 2.62% | 0.52% | 121.85 |
Financial data is updated regularly. All figures are in the company's reporting currency.